TherapeuticsMD | TXMD - Loan Capital


TherapeuticsMD reported $0 in Loan Capital for its fiscal quarter ending in March of 2022.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alterity Therapeutics Limited AUD 103.21K 73.88K Jun/2023
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.69B 1.37B Jun/2025
Grifols EUR 10.67B 564.4M Sep/2025
Novo Nordisk DKK 14.02B 224.49M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
TherapeuticsMD USD 0 0 Mar/2022